| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.006 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |